Accuray Inc (ARAY) - Cumulative Company Assets

Corporate emblem and logo of Accuray Inc (ARAY)

Accuray Incorporated (ARAY) generates revenue through the sale of advanced radiosurgery equipment and long-term software support. The market price movement of total assets is recorded at 456.73. System assembly relies on the procurement of precision components from external partners under strict supervision. Meanwhile, Accuray Incorporated (ARAY) maintains its position in a niche segment due to exceptional irradiation precision, avoiding price wars with industry leaders.

ARAY: Accuray Inc Aggregate Company Assets 07/04/2022 - 10/28/2026
Manufactured product of Accuray

Total assets determine the aggregate value of the company's resources, calculated inversely via return on assets (ROA) to assess the scale of the business. For Accuray Incorporated (ARAY), this metric reflects the capitalization of its technological base, including CyberKnife and Radixact systems. By analyzing the company's total resources, an investor can see the efficiency of integrating AI planning into the asset structure. The indicator's dynamics allow for an assessment of the mature business's stability and the risk of capital stagnation in obsolete solutions.

Competitors of Accuray Incorporated (ARAY)

beigene.com (ONC) - Company Assets|Company Total Assets HALO|Cumulative Company Assets Revolution Medicines Inc|Company Total Assets AAPG|Company Total Assets CGON (CG Oncology Therapeutics)|URGN - Aggregate Company Assets|Total Business Assets bicara.com BCAX|PSNL: Company Total Assets|ERAS - Cumulative Company Assets|Company Total Assets DCTH|YMAB (Y-mAbs Corp) - Company Assets|AURA - Aggregate Company Assets|Aggregate Asset Value Candel (CADL)|SELLAS Life Sciences (SLS) - Cumulative Company Assets|Aggregate Asset Value Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Company Total Assets|HURA - Cumulative Company Assets|Protara Therapeutics - Cumulative Company Assets|FATE: Company Total Assets|Aggregate Company Assets aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Aggregate Asset Value|Company Total Assets CSBR (Champions Oncology Inc)|Company Assets XBiotech USA|Company Total Assets CVM|Company Total Assets ostherapies.com (OSTX)|Radiopharm Theranostics - Company Total Assets|Cumulative Company Assets Artiva Biotherapeutics Inc. ARTV|ANL: Company Total Assets|Veru Corporation (VERU) - Cumulative Company Assets|TPST: Cumulative Company Assets|XLO (Xilio Therapeutics) - Company Total Assets|RENB - Aggregate Company Assets|Aggregate Asset Value Mural Bio|Company Total Assets KAPA|Company Total Assets onkuretherapeutics.com OKUR|GDTC: Cumulative Company Assets|CRIS - Company Assets|Cumulative Company Assets Apollomics Corp (APLM)|THAR - Aggregate Asset Value|advanbiomed.com - Company Total Assets|GNPX (Genprex Inc) - Company Total Asset Base|Aggregate Company Assets Calidi Biotherapeutics Inc. (CLDI)|Total Business Assets sunshinebiopharma.com|Company Total Assets XBIO (Xenetic Biosciences)|Cumulative Company Assets SLRX (Salarius Pharmaceuticals Inc)|PPBT: Aggregate Company Assets|American Oncology Network Inc - Company Assets|Aggregate Company Assets BeiGene, Ltd. (BGNE)|CKPT: Aggregate Asset Value|Aggregate Company Assets Elevation Oncology (ELEV)|ICAD (iCAD) - Total Asset Value of Company|Aggregate Company Assets IKNA (Ikena Oncology Inc.)|Company Assets NTBL|Viracta Therapeutics (VIRX) - Aggregate Company Assets|Aggregate Asset Value morphosys.com (MOR)|Company Total Assets NAYA (NAYA Biosciences Inc.)|AAPGV - Company Total Assets